Evidence map›Paper›PMID 36986750›Full record

ArticlePharmaceutics2023

Feasibility of Child-Resistant and Senior-Friendly Press-Through Packages: Potential of Different Materials.

Kiyomi Sadamoto, Hiroyuki Ura, Mikio Murata, Masaho Hayashi, Kiyoshi Kubota

Open access · goldAbstract read
In one paragraph

Article in Pharmaceutics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Kiyomi SadamotoDepartment of Clinical Pharmacy, Shonan University of Medical Science, 16-48 Kamishinano Totsuka, Yokohama 244-0806, Japan.ORCID 0000-0001-7670-8687
Hiroyuki UraDepartment of Clinical Pharmacy, Shonan University of Medical Science, 16-48 Kamishinano Totsuka, Yokohama 244-0806, Japan.
Mikio MurataMECSION, General Incorporated Association, 242-3 Guzo Hiratsuka, Hiratsuka 254-0906, Japan.
Masaho HayashiMECSION, General Incorporated Association, 242-3 Guzo Hiratsuka, Hiratsuka 254-0906, Japan.
Kiyoshi KubotaMECSION, General Incorporated Association, 242-3 Guzo Hiratsuka, Hiratsuka 254-0906, Japan.
Shonan University of Medical Sciences · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Press-through packaging (PTP) is the most common type of drug packaging in Japan, and a production procedure for PTP has been established at an acceptable cost. However, unknown problems and new needs with regard to safety among users of various age-groups still need to be examined. Considering accident reports involving children and older adults, the safety and quality of PTP and new forms of PTP, such as child-resistant and senior-friendly (CRSF) packaging, should be evaluated. We conducted an ergonomic study on children and older adults to compare types of commonly used PTP and new varieties of PTP. Opening tests were attempted by children and older adults using a common type of PTP (Type A) and child-resistant (CR) PTP (Types B1 and B2) made from soft aluminum foil. The same opening test was conducted on older patients with rheumatoid arthritis (RA). The results showed that CR PTP was difficult for children to open: only 1 out of 18 children could open Type B1. On the other hand, all eight of the older adults could open Type B1, and eight patients with RA could easily open Types B1 and B2. These findings suggest that the quality of CRSF PTP can be improved with the use of new materials.

Indexed as

childrenchild-resistant and senior-friendlyolder adultspress-through packagerheumatoid arthritissoft aluminum material

Identifiers

PMID36986750
PMCPMC10058415
OpenAlexW4323850387

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.